Sens. Hatch, Alexander Expected To Helm Health Panels In Senate
Executive Summary
Orrin Hatch, the veteran of major pharmaceutical legislative initiatives, is in line to head the Finance Committee with the change to Republican control of the Senate. The Health, Education, Labor and Pensions Committee – with jurisdiction over biomedical R&D and public health – will be headed by Lamar Alexander, in his first opportunity to chair a committee.
You may also be interested in...
IPAB’s Tough Road Ahead Shown As Republicans Opt Not To Help Find Members
House Speaker Boehner and Senate Majority Leader McConnell “respectfully decline” the president’s request to submit names of individuals to serve on the Medicare Independent Payment Advisory Board.
Senior Senators Seek Details On Government Audits Of 340B Entities
Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.
Pink Sheet Podcast: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed, an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees, and Japan’s PMDA opening an office in Washington D.C.